TNGX logo

Tango Therapeutics, Inc. (TNGX)

Profile

Full Name

Tango Therapeutics, Inc.

Ticker

NASDAQ: TNGX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 3, 2020

Indexes

Not included

Website

https://www.tangotx.com

Employees

155

Key Details

Price

$9.11(4.66%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$42.07M(15.17% YoY)

Annual EPS

-$1.19(-10.89% YoY)

PE Ratio

-

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $9.11
    TNGX price is $9.11

    30-Day Relative Volume

    1.04
    TNGX 30-day relative volume is 1.04

    Price Performance

    Price 1-Day Change

    +4.66%
    TNGX price is up +4.66% today

    Price YTD Change

    +194.66%
    TNGX price is up +194.66% since January 1st

    Price 1-Year Change

    +31.77%
    TNGX price is up +31.77% year-on-year

    Price 3-Year Change

    +76.11%
    TNGX price is up +76.11% over the past 3 years

    Price Range

    Price All-Time High

    $18.84
    TNGX price is currently -51.67% below its historical high of $18.84

    Price 3-Year Low

    $1.03
    TNGX price is currently +783.98% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $1.01B
    TNGX market cap is $1.01 billion

    Market Cap 3-Year Change

    +122.49%
    TNGX market cap is up +122.49% over the past 3 years

    Market Cap All-Time High

    $1.51B
    TNGX market cap is currently -33.06% below its historical high of $1.51 billion

    Market Cap Sector Percentile

    70.99%
    TNGX market cap is higher than 70.99% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.58%
    TNGX shares outstanding is up +3.58% year-on-year

    Shares Outstanding 3-Year Change

    +26.34%
    TNGX shares outstanding is up +26.34% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.47
    TNGX beta is 1.47

    200-day SMA

    $4.12
    TNGX price is currently +121.26% above its 200-day simple moving average

    50-day SMA

    $7.19
    TNGX price is currently +26.64% above its 50-day simple moving average

    14-Day RSI

    63.59
    TNGX 14-day relative strength index is 63.59

    Volume

    1.04
    TNGX 30-day relative volume is 1.04

    ATR

    $0.60
    TNGX average true range is $0.60

    10-day Historical Volatility

    115.78%
    TNGX 10-day historical volatility is 115.78%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $42.07M
    TNGX annual revenue is $42.07 million

    Revenue Analysts Estimate

    $53.92M
    TNGX annual revenue is currently -21.98% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +15.17%
    TNGX annual revenue is up +15.17% year-on-year

    Revenue Sector Percentile

    60.33%
    TNGX annual revenue is higher than 60.33% of companies in Healthcare sector

    EPS

    EPS

    -$1.19
    TNGX annual earnings per share is -$1.19

    EPS Analysts Estimate

    -$1.09
    TNGX annual earnings per share is currently -9.86% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -10.89%
    TNGX annual earnings per share is down -10.89% year-on-year

    EPS Sector Percentile

    51.22%
    TNGX annual earnings per share is higher than 51.22% of companies in Healthcare sector

    Profit

    Gross Profit

    $39.57M
    TNGX annual gross profit is $39.57 million

    Gross Margin

    94.06%
    TNGX annual gross profit margin is 94.06%

    Operating Profit

    -$145.59M
    TNGX annual operating income is -$145.59 million

    Operating Margin

    -346.09%
    TNGX annual operating profit margin is -346.09%

    Net Income

    -$130.30M
    TNGX annual net profit is -$130.30 million

    Net Margin

    -309.73%
    TNGX annual net profit margin is -309.73%

    Expenses

    Total Expenses

    $187.66M
    TNGX annual total expenses is $187.66 million

    Operating Expenses

    $187.66M
    TNGX annual total operating expenses is $187.66 million

    Cost Of Goods Sold

    $2.50M
    TNGX annual cost of goods sold is $2.50 million

    Selling, General & Administrative Expenses

    $43.75M
    TNGX annual SG&A is $43.75 million

    Depreciation & Amortization

    $2.50M
    TNGX annual D&A is $2.50 million

    Interest Expense

    $0.00
    TNGX annual interest expense is $0.00

    Income Tax

    $208.00K
    TNGX annual income tax is $208.00 thousand

    EBIT & EBITDA

    EBIT

    -$145.59M
    TNGX annual earnings before interest & taxes is -$145.59 million

    EBITDA

    -$143.10M
    TNGX annual EBITDA is -$143.10 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $328.94M
    TNGX annual total assets is $328.94 million

    Non Current Assets

    $50.15M
    TNGX annual long term assets is $50.15 million

    Current Assets

    $266.34M
    TNGX annual total current assets is $266.34 million

    Cash and Cash Equivalents

    $69.53M
    TNGX annual cash & cash equivalents is $69.53 million

    Accounts Receivable

    -
    TNGX annual accounts receivable value is unknown

    Inventory

    $0.00
    TNGX annual inventory is $0.00

    Liabilities

    Total Liabilities

    $129.43M
    TNGX annual total liabilities is $129.43 million

    Long Term Liabilities

    $78.81M
    TNGX annual total long term liabilities is $78.81 million

    Current Liabilities

    $38.17M
    TNGX annual current liabilities is $38.17 million

    Accounts Payable

    $1.60M
    TNGX annual accounts payable is $1.60 million

    Debt

    Total Debt

    $36.49M
    TNGX annual total debt is $36.49 million

    Total Debt 1-Year Change

    -6.24%
    TNGX annual total debt is down -6.24% year-on-year

    Long Term Debt

    $34.04M
    TNGX annual long term debt is $34.04 million

    Short Term Debt

    $2.45M
    TNGX annual short term debt is $2.45 million

    Equity & Capital

    Shareholders Equity

    $199.52M
    TNGX annual stockholders equity is $199.52 million

    Book Value

    $199.52M
    TNGX annual book value is $199.52 million

    Retained Earnings

    -$501.56M
    TNGX annual retained earnings is -$501.56 million

    Working Capital

    $228.17M
    TNGX annual working capital is $228.17 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$131.50M
    TNGX annual cash from operations is -$131.50 million

    Cash From Operations 1-Year Change

    -11.46%
    TNGX annual cash from operations is down -11.46% year-on-year

    Cash From Investing

    $86.13M
    TNGX annual cash from investing is $86.13 million

    Cash From Investing 1-Year Change

    +107.9%
    TNGX annual cash from investing is up +107.9% year-on-year

    Cash From Financing

    $47.66M
    TNGX annual cash from financing is $47.66 million

    Cash From Financing 1-Year Change

    -42.16%
    TNGX annual cash from financing is down -42.16% year-on-year

    CAPEX

    CAPEX

    $754.00K
    TNGX annual capital expenditures is $754.00 thousand

    CAPEX 1-Year Change

    -50.59%
    TNGX annual capital expenditures is down -50.59% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$132.25M
    TNGX annual free cash flow is -$132.25 million

    Free Cash Flow 1-Year Change

    -10.67%
    TNGX annual free cash flow is down -10.67% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    94.06%
    TNGX annual gross profit margin is 94.06%

    Operating Margin

    -346.09%
    TNGX annual operating profit margin is -346.09%

    Net Margin

    -309.73%
    TNGX annual net profit margin is -309.73%

    ROA & ROE

    ROA

    -34.96%
    TNGX annual return on assets is -34.96%

    ROE

    -57.58%
    TNGX annual return on equity is -57.58%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    TNGX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    TNGX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    7.51
    TNGX price to book ratio is 7.51

    PB Ratio Sector Percentile

    84.19%
    TNGX price to book ratio is higher than 84.19% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    41.69
    TNGX price to sales ratio is 41.69

    PS Ratio Sector Percentile

    84.72%
    TNGX price to sales ratio is higher than 84.72% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $866.82M
    TNGX enterprise value is $866.82 million

    Enterprise Value Sector Percentile

    70.3%
    TNGX enterprise value is higher than 70.3% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -5.60
    TNGX EV/EBITDA is -5.60

    EV/EBITDA Sector Percentile

    23.62%
    TNGX EV/EBITDA is higher than 23.62% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    6.98
    TNGX annual current ratio is 6.98

    Quick Ratio

    6.98
    TNGX annual quick ratio is 6.98

    Leverage

    Debt To Equity

    0.00
    TNGX annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -
    TNGX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    1
    TNGX piotroski f-score is 1

    Altman Z-Score

    2.06
    TNGX altman z-score is 2.06

    Analyst ratings

    Recent major analysts updates

    Aug 19, 25 Piper Sandler
    Overweight
    Aug 6, 25 Guggenheim
    Buy
    Apr 14, 25 HC Wainwright & Co.
    Buy
    Dec 5, 24 Cantor Fitzgerald
    Overweight
    Nov 11, 24 B. Riley Securities
    Buy
    Nov 8, 24 HC Wainwright & Co.
    Buy
    Nov 7, 24 Guggenheim
    Buy
    Oct 28, 24 HC Wainwright & Co.
    Buy
    Sep 10, 24 HC Wainwright & Co.
    Buy
    Aug 8, 24 Wedbush
    Outperform

    Institutional Ownership

    Screeners with TNGX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Tango Therapeutics, Inc.?
    • Does Tango Therapeutics, Inc. pay dividends?
    • What sector is Tango Therapeutics, Inc. in?
    • What industry is Tango Therapeutics, Inc. in?
    • What country is Tango Therapeutics, Inc. based in?
    • When did Tango Therapeutics, Inc. go public?
    • Is Tango Therapeutics, Inc. in the S&P 500?
    • Is Tango Therapeutics, Inc. in the NASDAQ 100?
    • Is Tango Therapeutics, Inc. in the Dow Jones?
    • When was Tango Therapeutics, Inc.'s last earnings report?
    • When does Tango Therapeutics, Inc. report earnings?

    What is the ticker symbol for Tango Therapeutics, Inc.?

    The ticker symbol for Tango Therapeutics, Inc. is NASDAQ:TNGX

    Does Tango Therapeutics, Inc. pay dividends?

    No, Tango Therapeutics, Inc. does not pay dividends

    What sector is Tango Therapeutics, Inc. in?

    Tango Therapeutics, Inc. is in the Healthcare sector

    What industry is Tango Therapeutics, Inc. in?

    Tango Therapeutics, Inc. is in the Biotechnology industry

    What country is Tango Therapeutics, Inc. based in?

    Tango Therapeutics, Inc. is headquartered in United States

    When did Tango Therapeutics, Inc. go public?

    Tango Therapeutics, Inc.'s initial public offering (IPO) was on September 3, 2020

    Is Tango Therapeutics, Inc. in the S&P 500?

    No, Tango Therapeutics, Inc. is not included in the S&P 500 index

    Is Tango Therapeutics, Inc. in the NASDAQ 100?

    No, Tango Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Tango Therapeutics, Inc. in the Dow Jones?

    No, Tango Therapeutics, Inc. is not included in the Dow Jones index

    When was Tango Therapeutics, Inc.'s last earnings report?

    Tango Therapeutics, Inc.'s most recent earnings report was on August 5, 2025

    When does Tango Therapeutics, Inc. report earnings?

    The next expected earnings date for Tango Therapeutics, Inc. is November 5, 2025
    On this page